An interventional study of Orientation day with rapid response nurse in Deterioration, Clinical, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Other
This study will measure knowledge, confidence, and nursing practice outcomes related to the effectiveness and feasibility of a 12-hour educational clinical intervention for NGNs during orientation.
New graduate nurses (NGN) are faced with multiple challenges as they orient to their role as a registered nurse. Acute care NGN are charged with caring for an increasingly complex patients with high acuity. When a patient begins to decline in the inpatient setting, it is termed patient deterioration. Patient deterioration is defined in differing ways depending on the disposition of the patient and their particular clinical picture, but the term generally refers to a patient who is declining in health rapidly due to acute adverse events during their hospitalization. This study will measure knowledge, confidence, and nursing practice outcomes related to the effectiveness and feasibility of a 12-hour educational clinical intervention for NGNs during orientation.
51 studies on the registry are indexed under Clinical Deterioration; 15 are open to participants now.
This study's planned enrollment of 300 is close to the median of 300 across 25 interventional studies indexed under Clinical Deterioration.
Browse Clinical Deterioration studies →University of Colorado, Denver is the lead sponsor of 1,540 studies on the registry; 319 are open to participants now.
Of its 146 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group of newly graduate will spend one day of orientation with a rapid response nurse
Other: Orientation day with rapid response nurse
This group of new graduate nurses will receive routine orientation
This orientation day is spending attending rapid responses with a rapid response nurse.
Also known as: orientation
Clinicians' Attitudes towards Responding and Escalating care of Deteriorating patients scale (CARED)
Assessment of 1) beliefs about rapid response systems, 2) fears about escalating care, and 3) perceived confidence in responding. This is a 22-item scale which uses a 5-point Likert scale. Scores ranges from 22-110. Higher scores indicate that participants have increase confidence that rapid response teams will support them, decreased fears about engaging with rapid response teams, and increase confidence with responding to deteriorating patients.
Time frame: The participants will complete a baseline survey (pre-survey) at enrollment at the start of their orientation. Approximately 10-12 weeks later, the participants will complete a post-survey after they have completed orientation.
Activation of Rapid Responses
Assessment of whether new graduate nurse or virtual intensive care unit initiated rapid response. New graduate nurse initiation of rapid response demonstrates frontline nurse detected the patient deterioration versus a late recognition by the virtual intensive care unit.
Time frame: Participant's engagement with the rapid response team will be examined from the beginning of their orientation through the end of their first year (52 weeks in total).
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →